Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 168,000 | 112,400 | 179,300 | 271,513 | 308,304 |
| Receivables | 270,700 | 271,100 | 146,100 | 148,474 | 120,479 |
| Inventories | 222,500 | 205,800 | 142,800 | 74,002 | 60,887 |
| Other current assets | 0 | 0 | 0 | 0 | 29,282 |
| TOTAL | $686,200 | $620,800 | $485,400 | $510,218 | $537,410 |
| Non-Current Assets | |||||
| PPE Net | 542,300 | 510,200 | 407,200 | 376,448 | 327,808 |
| Intangibles | 979,500 | 1,021,300 | 168,700 | 74,866 | 81,759 |
| Other Non-Current Assets | 119,300 | 77,100 | 8,900 | 8,579 | 90,507 |
| TOTAL | $1,641,100 | $1,608,600 | $584,800 | $459,893 | $500,074 |
| Total Assets | $2,327,300 | $2,229,400 | $1,070,200 | $970,111 | $1,037,484 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,900 | 10,100 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 94,800 | 80,700 | 41,800 | 34,649 | 37,970 |
| Accrued Expenses | 101,900 | 88,900 | 42,700 | 40,905 | 38,205 |
| Other current liabilities | 6,700 | 20,700 | 2,400 | 3,266 | 2,109 |
| TOTAL | $216,300 | $200,400 | $100,100 | $105,856 | $99,611 |
| Non-Current Liabilities | |||||
| Long Term Debt | 798,400 | 784,500 | 13,500 | 248,094 | 246,892 |
| Deferred Revenues | N/A | N/A | 13,200 | 7,036 | 3,979 |
| Other Non-Current Liabilities | 74,600 | 103,600 | 27,000 | 11,523 | 27,538 |
| TOTAL | $1,022,500 | $1,018,100 | $57,800 | $268,050 | $277,856 |
| Total Liabilities | $1,238,800 | $1,218,500 | $157,900 | $373,906 | $377,467 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,000 | 51,200 | 49,495 | 40,688 | 39,474 |
| Common Shares | 100 | 100 | 100 | 41 | 40 |
| Retained earnings | 421,800 | 367,300 | 337,100 | 254,480 | 351,139 |
| Other shareholders' equity | -9,500 | -5,100 | -3,200 | -4,751 | -3,133 |
| TOTAL | $1,088,500 | $1,010,900 | $912,300 | $596,205 | $660,017 |
| Total Liabilities And Equity | $2,327,300 | $2,229,400 | $1,070,200 | $970,111 | $1,037,484 |